Legal & General Group Plc - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$102,827
-94.8%
30,243
-88.8%
0.00%
-100.0%
Q2 2023$1,981,854
-33.0%
269,640
-5.6%
0.00%0.0%
Q1 2023$2,957,687
+28.1%
285,491
+46.0%
0.00%0.0%
Q4 2022$2,309,375
-39.0%
195,544
+8.4%
0.00%0.0%
Q3 2022$3,788,000
-22.0%
180,423
+15.4%
0.00%
-50.0%
Q2 2022$4,854,000
-44.1%
156,363
-26.1%
0.00%
-33.3%
Q1 2022$8,685,000
-3.6%
211,528
+2.1%
0.00%0.0%
Q4 2021$9,008,000
+29.1%
207,207
+48.7%
0.00%
+50.0%
Q3 2021$6,976,000
-4.9%
139,324
+19.7%
0.00%0.0%
Q2 2021$7,333,000
-29.4%
116,405
+4.1%
0.00%
-50.0%
Q1 2021$10,390,000
+16.6%
111,820
+12.4%
0.00%
+33.3%
Q4 2020$8,911,000
-14.6%
99,453
-1.5%
0.00%
-40.0%
Q3 2020$10,433,000
-27.9%
100,961
-44.8%
0.01%
-28.6%
Q2 2020$14,463,000
+83.0%
182,892
+33.6%
0.01%
+40.0%
Q1 2020$7,903,000
+7.3%
136,848
+0.3%
0.01%
+25.0%
Q4 2019$7,363,000
+13.2%
136,475
+9.7%
0.00%
+33.3%
Q3 2019$6,507,000
+8.1%
124,434
-0.2%
0.00%0.0%
Q2 2019$6,022,000
-4.1%
124,651
+0.3%
0.00%
-25.0%
Q1 2019$6,277,000
+0.7%
124,239
+17.8%
0.00%
-20.0%
Q4 2018$6,231,000
-8.7%
105,436
+1.6%
0.01%0.0%
Q3 2018$6,826,000
+67.1%
103,739
+28.5%
0.01%
+66.7%
Q2 2018$4,085,000
+4.7%
80,757
+8.5%
0.00%0.0%
Q1 2018$3,902,000
+17.5%
74,427
+4.2%
0.00%
+50.0%
Q4 2017$3,321,000
+16.7%
71,406
+1.5%
0.00%0.0%
Q3 2017$2,845,000
+24.7%
70,378
+4.5%
0.00%0.0%
Q2 2017$2,282,000
+28.6%
67,333
+10.1%
0.00%0.0%
Q1 2017$1,775,000
-3.4%
61,140
+9.3%
0.00%0.0%
Q4 2016$1,838,000
+112.2%
55,927
+99.2%
0.00%
+100.0%
Q3 2016$866,000
+581.9%
28,071
+524.1%
0.00%
Q2 2016$127,000
-21.6%
4,4980.0%0.00%
Q1 2016$162,000
-3.6%
4,498
+6.3%
0.00%
Q4 2015$168,000
+37.7%
4,2330.0%0.00%
Q3 2015$122,000
-11.6%
4,2330.0%0.00%
Q2 2015$138,000
+12.2%
4,2330.0%0.00%
Q1 2015$123,000
+4.2%
4,2330.0%0.00%
Q4 2014$118,000
+28.3%
4,2330.0%0.00%
Q3 2014$92,0004,2330.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders